MedPath

Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy

Not yet recruiting
Conditions
Gastric Cancer Stage
Esophageal Cancer
Gastroparesis
Registration Number
NCT07104214
Lead Sponsor
Zhejiang University
Brief Summary

Gastric retention not only compromises the quality of endoscopic examination but also significantly increases the risk of reflux and aspiration in sedated patients. Aspiration of gastric contents represents a critical anesthesia-related complication during the perioperative period, carrying substantial implications for anesthetic management. With the growing volume of sedated gastroscopy procedures, predicting gastric retention has become an urgent clinical priority. This prospective study aims to establish a standardized gastric residual volume (GRV) grading system to evaluate both the volume of retained gastric contents and its contributing factors in patients undergoing upper gastrointestinal endoscopy. We will systematically assess the impact of demographic characteristics, comorbidities, and medication history on gastric emptying function. This study will facilitate establishment of an endoscopy-based simplified assessment system for gastric retention.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
5000
Inclusion Criteria
  • Age ≥18 years.
  • Patients scheduled for elective sedated gastroscopy or sedated gastro-colonoscopy.
  • Participant provides informed consent.
Exclusion Criteria
  • Acute upper gastrointestinal bleeding (active hematemesis, melena, or confirmed UGIB within 24h).
  • Emergency endoscopic procedures
  • Known pregnancy or lactation
  • Subjects deemed ineligible by investigators

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of delayed gastric emptying (defined as endoscopic gastric residual volume ≥ Grade 2) assessed by standardized endoscopic grading systemPatients will be followed for the duration of hospital stay, an expected average about 2 hours

Measurement Tool: Standardized endoscopic gastric residual volume grading system : Grade 0:Stomach completely clean, no visible residue; Grade 1:Small amount of clear liquid (\<1.5 mL/kg or \<100 mL), no solid components; Grade 2:Liquid ≥1.5 mL/kg (or ≥100 mL) or small solid fragments (\<5 mm); Grade 3:Large amount of liquid (\>200 mL) or significant solid residue (≥5 mm fragments) Grade 4:Visible undigested food chunks or intact food pieces Data Collection: Two physicians independently assessed gastric residue (liquid/solid), measuring volume using a graduated suction bottle, with video recordings archived for third-party review.

Statistical Methods: The incidence (%) of gastric retention (≥Grade 2) was calculated. Multivariate logistic regression analyzed risk factors, and ROC curves evaluated the model's predictive performance (AUC).

Secondary Outcome Measures
NameTimeMethod
Correlation between gastric residual volume (GRV) grading and Gastroparesis Cardinal Symptom Index (GCSI) scores (range: 0-20, higher scores indicate worse symptoms)Patients will be followed for the duration of hospital stay, an expected average about 2 hours

The standardized Gastroparesis Cardinal Symptom Index (GCSI) was used to quantify the following core symptoms:

Nausea (frequency \& intensity): 0 (none) to 5 (severe, persistent daily).

Vomiting (episode frequency): 0 (none) to 5 (≥3 times/day).

Postprandial fullness (duration): 0 (none) to 5 (\>4 hours).

Early satiety (food intake limitation): 0 (normal eating) to 5 (eating \<25% of usual amount).

Statistical Analysis: The correlation between GRV grades (0-4) and the total GCSI score was assessed using Spearman's rank correlation coefficient.

Development and validation of a simplified clinical scoring system for gastric retention risk stratification (score range: 0-10, higher scores indicate higher risk)Patients will be followed for the duration of hospital stay, an expected average about 2 hours

Development Method: Based on multivariate logistic regression results, independent predictive factors (e.g., diabetes, GLP-1 medication use) were converted into a clinical scoring system (e.g., 1-2 points per factor).

Validation Process:

Discrimination: The AUC (area under the curve) of the scoring system was calculated in the validation cohort (target \>0.7).

Calibration: The Hosmer-Lemeshow test was used to assess the agreement between predicted and observed risks.

Example Scoring Range:

0-3 points: Low risk、4-6 points: Moderate risk、7-10 points: High risk.

Incidence of Gastric Retention in Patients Undergoing GastroscopyPatients will be followed for the duration of hospital stay, an expected average about 2 hours

Trial Locations

Locations (3)

The First Affiliated Hospital, Zhejiang University School of Medicine

🇨🇳

Hangzhou, Zhejiang, China

Zhejiang Cancer hospital

🇨🇳

Hangzhou, Zhejiang, China

The Fourth Affiliated Hospital, Zhejiang University School of Medicine

🇨🇳

Yiwu, Zhejiang, China

The First Affiliated Hospital, Zhejiang University School of Medicine
🇨🇳Hangzhou, Zhejiang, China
Diansan Su, Dr
Principal Investigator
Mingxia Su, Dr
Contact
+8613516713435
Mingxia Xu
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.